Spectral Instruments Imaging
Private Company
Funding information not available
Overview
Spectral Instruments Imaging is a private medical device company providing high-performance preclinical imaging systems. Its core value proposition is delivering unmatched sensitivity, robustness, and ease-of-use for bioluminescence and fluorescence imaging, supported by its proprietary Aura software and patented excitation technology. The company targets academic, pharmaceutical, and biotechnology research labs, competing on superior data quality, instrument reliability, and strong customer support. Its strategic focus is on advancing in vivo imaging to reveal complex biological processes for drug discovery and basic research.
Technology Platform
Proprietary in vivo optical imaging systems featuring patented FLI Excitation (100x more light), high-sensitivity cameras, and the Aura software suite for 2D/3D bioluminescence, fluorescence, and X-ray imaging.
Opportunities
Risk Factors
Competitive Landscape
Competes directly with PerkinElmer (IVIS series) and Bruker in the preclinical optical imaging market. SII differentiates on superior hardware sensitivity (patented excitation), robust design for core labs, and a free, powerful software platform (Aura). The landscape is characterized by high technical specifications and a focus on throughput and quantitative data.